Correlation Between Dupont De and Antisense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dupont De and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Dupont De and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Antisense Therapeutics.
Diversification Opportunities for Dupont De and Antisense Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dupont and Antisense is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Antisense Therapeutics go up and down completely randomly.
Pair Corralation between Dupont De and Antisense Therapeutics
Allowing for the 90-day total investment horizon Dupont De is expected to generate 17.55 times less return on investment than Antisense Therapeutics. But when comparing it to its historical volatility, Dupont De Nemours is 12.14 times less risky than Antisense Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Antisense Therapeutics Limited is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 6.50 in Antisense Therapeutics Limited on August 29, 2024 and sell it today you would lose (2.30) from holding Antisense Therapeutics Limited or give up 35.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Antisense Therapeutics Limited
Performance |
| Timeline |
| Dupont De Nemours |
| Antisense Therapeutics |
Dupont De and Antisense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Antisense Therapeutics
The main advantage of trading using opposite Dupont De and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.| Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide | Dupont De vs. LyondellBasell Industries NV |
| Antisense Therapeutics vs. Amexdrug | Antisense Therapeutics vs. Aion Therapeutic | Antisense Therapeutics vs. Alterola Biotech | Antisense Therapeutics vs. The BC Bud |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |